BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36396063)

  • 1. Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium.
    García-Pardo M; Chang A; Schmid S; Dong M; Brown MC; Christiani D; Tindel HA; Brennan P; Chen C; Zhang J; Ryan BM; Zaridze D; Schabath MB; Leal LF; Reis RM; Tardon A; Fernández-Tardon G; Shete SS; Andrew A; Brenner H; Xu W; Hung RJ; Liu G
    J Thorac Oncol; 2023 Mar; 18(3):313-323. PubMed ID: 36396063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of surgery for stage IIIa non-small cell lung cancer].
    Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
    Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
    Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
    JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium".
    Zhang Y; Zhang J
    J Thorac Oncol; 2023 Sep; 18(9):e95-e96. PubMed ID: 37599054
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Response to Letter to the Editor "Respiratory and Cardiometabolic Comorbidities and Stage I-III Non-Small Cell Lung Cancer (NSCLC) Survival: A Pooled Analysis From the International Lung Cancer Consortium".
    García-Pardo M; Liu G
    J Thorac Oncol; 2023 Sep; 18(9):e96-e97. PubMed ID: 37599055
    [No Abstract]   [Full Text] [Related]  

  • 10. Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
    Wei S; Tian J; Song X; Wu B; Liu L
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):145-155. PubMed ID: 28980067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
    Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
    Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis.
    Kravchenko J; Berry M; Arbeev K; Lyerly HK; Yashin A; Akushevich I
    Lung Cancer; 2015 Apr; 88(1):85-93. PubMed ID: 25704956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
    Shepshelovich D; Xu W; Lu L; Fares A; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Wu X; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Brown MC; Liu G; Hung RJ
    J Thorac Oncol; 2019 Sep; 14(9):1594-1607. PubMed ID: 31163278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world surgical treatment patterns and clinical outcomes in patients with stages IA-IIIA non-small cell lung cancer: a retrospective multicentric observational study involving 11,958 patients.
    Sun D; Hu J; Li X; He J; Xu L; Fu X; Liu Y; Liu D; Chen P; Zhang X; Liu L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8213-8223. PubMed ID: 37062036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
    Duan H; Liang L; Xie S; Wang C
    BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidities and relevant outcomes, commonly associated with cancer, of patients newly diagnosed with advanced non-small-cell lung cancer in Sweden.
    Linden S; Redig J; Banos Hernaez A; Nilsson J; Bartels DB; Justo N
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13171. PubMed ID: 31578054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007-2016.
    Shah M; Parmar A; Chan KKW
    Cancer Med; 2020 May; 9(10):3407-3416. PubMed ID: 32196964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.